Skip to main content

Kineta, Inc.

KADelisted Oct 15, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001445283

Kineta, Inc. was delisted on Oct 15, 2024; its insiders filed their last Form 4 on Jul 2, 2025; 26 institutions reported holding it in 13F filings for Q2 2024, worth $388.5K in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
26
Q2 2024, +1 vs. previous quarter
13F value
$388.5K
Reported value at the end of Q2 2024
Superinvestors holding
0
At the end of Q2 2024

From SEC filings, in USD.

Revenue, FY2024
$0
−100.0% year over year
Net income, FY2024
-$17.1M
No comparable prior period
Free cash flow, FY2024
–
No comparable prior period
Revenue, Q1 FY2025
–
No comparable prior period

Superinvestors holding KA, Q2 2024

Go to the superinvestors tab

No superinvestor reported holding KA at the end of Q2 2024.

Latest insider trades

See all insider trades

Open-market purchases and sales by Kineta, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2023 (view filing)Dec 4-62 daysBartoszek Raymond J.DirectorPPurchase+2.25K$4.42+$9.96K+15.0%17.2K after3 lots
Nov 30, 2023 (view filing)Nov 282 daysPhilips Craig W.PresidentPPurchase+3.00K$3.27+$9.81K+5.2%60.8K after
Nov 30, 2023 (view filing)Nov 28-292 daysIadonato ShawnChief Executive OfficerPPurchase+5.00K$3.48+$17.4K+0.7%675.2K after2 lots
Sep 21, 2023 (view filing)Sep 20-211 dayPhilips Craig W.PresidentPPurchase+3.50K$2.42+$8.48K+6.4%57.8K after2 lots
Sep 21, 2023 (view filing)Sep 201 dayKenny PaulineGeneral Counsel & SecretaryPPurchase+1.50K$2.58+$3.87K+8.9%18.4K after
Sep 21, 2023 (view filing)Sep 201 dayIadonato ShawnChief Executive OfficerPPurchase+10.0K$2.50+$25.0K+1.5%670.2K after
Sep 21, 2023 (view filing)Sep 192 daysBartoszek Raymond J.DirectorPPurchase+2.00K$2.37+$4.74K+15.4%15.0K after
Sep 19, 2023 (view filing)Sep 181 dayBaker KeithChief Financial OfficerPPurchase+5.00K$2.13+$10.7K+42.1%16.9K after
Sep 19, 2023 (view filing)Sep 15-184 daysBartoszek Raymond J.DirectorPPurchase+3.00K$2.10+$6.29K+30.1%13.0K after2 lots
Sep 15, 2023 (view filing)Sep 141 dayGuillaudeux ThierryChief Scientific OfficerPPurchase+10.0K$2.00+$20.0K+85.5%21.7K after

Top 10 13F holders, Q2 2024

See all 26 holders

The largest institutional positions in Kineta, Inc. at the end of Q2 2024; share changes are against Q1 2024.

Institutions holding KA in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
PFG Investments, LLC326,988$173.5K0.01%+326,988New
Vanguard Group Inc59,326$31.5K0.00%00.0%Unchanged
Geode Capital Management, LLC57,755$30.7K0.00%+7,724+15.4%Added
Renaissance Technologies LLC40,715$21.6K0.00%+27,671+212.1%Added
Northern Trust Corp33,349$17.7K0.00%−10.0%Reduced
Colony Group, LLC32,709$17.0K0.00%−59,688−64.6%Reduced
Two Sigma Securities, LLC25,613$13.6K0.00%−2,039−7.4%Reduced
Evergreen Capital Management LLC20,852$11.1K0.00%00.0%Unchanged
Brighton Jones LLC20,786$11.0K0.00%+137+0.7%Added
Element Pointe Advisors, LLC17,696$9.39K0.00%00.0%Unchanged